Back to Journals » Biologics: Targets and Therapy » Volume 12 » Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
Please verify you are not a robot.
Back to Journals » Biologics: Targets and Therapy » Volume 12 » Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
Please verify you are not a robot.